Home Contact Us

Home
Topic: Osimertinib Mesylate, EGFR Inhibitor, NSCLC, Cancer Treatment, Pharmaceutical Intermediate, T790M Mutation, Targeted Therapy

Products for Topic: Osimertinib Mesylate, EGFR Inhibitor, NSCLC, Cancer Treatment, Pharmaceutical Intermediate, T790M Mutation, Targeted Therapy

Osimertinib Mesylate

Osimertinib Mesylate

Start Your Journey to Higher Quality

Reach out to our technical specialists today for customized solutions, samples, and a detailed quote. We are excited to build a brilliant future together.

Send an Inquiry by Email

NINGBO INNO PHARMCHEM CO.,LTD.

Add: 163 Ruiqing Road,Ningbo Zhejiang 315000 China | Tel：+86 574 87319282 / 87314919

© 2025 All Rights Reserved.